Type 2 diabetes is becoming a growing global health epidemic, affecting millions of people worldwide as their bodies develop insulin resistance and a progressive inability to produce enough insulin.
This chronic disease requires that patients manage their condition, focusing mostly on controlling blood sugar levels through medication, diet, and physical activity. Yet, these approaches often fall short of addressing the disease’s core mechanisms. And that can lead to long-term complications and a threat to overall health.
As a leading stem cell clinic and research organization, BioXcellerator enjoys a reputation of leadership in a transformative approach to treating type 2 diabetes. Charting a new course based on new research, BioXcellerator scientists are developing new treatments using mesenchymal stem cells (MSCs) to better treat this pervasive disease.
Conventional Management of Type 2 Diabetes: Addressing Symptoms, Not Causes
The standard approach to managing type 2 diabetes has largely been reactive. The main objective to such treatments is to keep blood sugar levels in check through hypoglycemic medications, insulin therapy, and lifestyle interventions.
While these methods can be effective in easing symptoms and reducing the risk of complications, they fall short of really treating the disease itself or change its trajectory. It’s like putting a bandage on a wound, but the bandage doesn’t heal a wound.
Patients often face the burden of following medication schedules, potential side effects, and the psychological toll of chronic disease management. Unfortunately, the progressive nature of type 2 diabetes means that many patients will eventually require insulin therapy, further complicating their treatment regimen.
The BioXcellerator Paradigm Shift: Mesenchymal Stem Cell Therapy
In contrast to the traditional symptom-focused treatments, BioXcellerator is pioneering using mesenchymal stem cells to target the root causes of type 2 diabetes. This is based on research that reveals how these cells can:
- Improve Insulin Sensitivity and Modulate Inflammation: MSCs demonstrate an ability to modulate the immune system and reduce chronic inflammation, a key contributor to insulin resistance. By addressing the inflammatory processes seen in type 2 diabetes, MSC therapy may help improve insulin sensitivity and glucose metabolism.
- Promote Beta Cell Regeneration: The potential of MSCs to help regenerate damaged beta cells that produce insulin could result in a groundbreaking shift in diabetes treatment. This regenerative capability can help restore the pancreas’s ability to produce insulin, which is the key challenge of managing type 2 diabetes
- Stimulate Angiogenesis to Improve Pancreatic Function: Angiogenesis, the formation of new blood vessels, is critical for the survival and function of newly formed or regenerated beta cells. Research suggests that MSCs may help support this process to keep the blood supply to the pancreatic tissue at appropriate level, which can optimize insulin production.
Patient Stories of Hope and Transformation
Type 2 diabetes is a disease often diagnosed at older ages. As the body ages, a less-than-ideal diet and limited physical activity can cause increasing insulin resistance.
At our clinic, we treat many patients across a wide variety of age-related conditions.
One patient, Israel Robles, wanted to stay active even he was getting older. He had been concerned about pain and that “My energy level is not as good as it as good as it used to be 10 or 15 years ago.”
He explains that he looks forward to feeling rejuvenated. Israel also explained that his son, a physician, had been treated at our clinic was “feeling 100% better” helped convince him to also receive mesenchymal stem cell therapy.
Israel says, “I know I’m going to be a lot healthier now that I have this rejuvenation system through my body.”
Another patient, Donald Pumpherey, had been an active athlete but he began to suffer from a variety of types of arthritic pain.
As he recalls, “Orthopedists were recommending surgery on my neck and surgery to replace both my knees and so, I just started researching and found this place.”
“Before coming to BioXcellerator, I was eating ibuprofens like they were candy. I couldn’t stay out of pain,” Donald explained. But after treatment, “my pain levels just kept decreasing until I was in zero pain.” Based on his experience, he returned to our clinic for additional treatments.
These stories show how mesenchymal stem cells can be used to treat a variety of conditions and optimize overall health thanks to the regenerative properties of these cells, which may hold promise for helping address insulin resistance of type 2 diabetes.
The Science Behind BioXcellerator MSC Therapy
The cornerstone of our approach to stem cell therapy is based on research, evidence, and scientific excellence.
Our research suggests that a specific type of MSC from the Wharton’s jelly in donated umbilical cords demonstrate high potency.
At our on-site lab, we take these cells, culture and expand them, and test them to create cells with the highest-possible potency – BioXcellerator Signature Cells.
In addition to our clinic, we also manage a research organization. You can find out more about the and about our science and learn more about how these cells may offer the potential to alter the course of type 2 diabetes, offering hope for far more improved treatments and outcomes.
The Future Is Now: A New Paradigm in Diabetes Care
The journey towards a cure for type 2 diabetes is complex because of the many factors that influence this disease, including , genetic predispositions, lifestyle factors, and environmental triggers.
But our science is uniquely positioned to address these complexities through a holistic approach that not only targets the symptoms but also the underlying causes of type 2 diabetes. As BioXcellerator continues to advance research and refine treatment protocols, the promise of a future where type 2 diabetes can be far more effectively managed, or even cured, becomes increasingly tangible.
Learn more about BioXcellerator and Stem Cell Therapy
In embracing the potential of mesenchymal stem cells, BioXcellerator is not just challenging the status quo; we are redefining it. To learn more, visit our website. And to find out if you may be a candidate for treatment, schedule a consultation with one of our experts.
